Further research with larger cohorts and over longer intervention periods is needed to confirm these observations and to determine the clinical utility of NUTM2A-AS1 and CCR3 as markers of the response to nutritional interventions in RA. This evidence concerns the gene NUTM2A and rheumatoid arthritis.